$3.29 $0.15 (4.8%)

04:30 PM EDT on 06/01/20

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

CAPS Rating: No stars

Current Price $3.29 Mkt Cap $76.6M
Open $3.29 P/E Ratio 0.00
Prev. Close $3.29 Div. (Yield) $0.00 (0.0%)
Daily Range $3.21 - $3.34 Volume 54,074
52-Wk Range $2.32 - $6.05 Avg. Daily Vol. 93,670

Caps

How do you think NASDAQ:ORMP will perform against the market?

Add Stock to CAPS Watchlist

All Players

21 Outperform
1 Underperform
 

All-Star Players

1 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ORMP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

AndrewGreenBull (94.23)
Submitted January 09, 2014

With less than 10m in cash and no candidate in phase 3, ORMP's hype can't last long. The market cap should be back down to 100M. Just my 2 cents

NASDAQ:ORMP VS S&P 500 (SPY)

Fools bullish on NASDAQ:ORMP are also bullish on:

Fools bearish on NASDAQ:ORMP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ORMP.

Recs

0
Member Avatar bfitz3309 (33.00) Submitted: 7/3/2018 10:10:46 AM : Outperform Start Price: $6.51 NASDAQ:ORMP Score: -61.57

Might get crushed on this but being T1D it would be nice to take a pill instead of a needle.

Recs

0
Member Avatar NHWeston102 (78.01) Submitted: 8/16/2016 12:42:13 PM : Outperform Start Price: $7.43 NASDAQ:ORMP Score: -95.52

This stock gets very little attention, not sure why, because if its orally-ingested insulin works and finds a market, it will dynamite the injectable insulin models that now hold the treatment monopoly [and keep raising prices].

Recs

0
Member Avatar jamz50patt (< 20) Submitted: 6/25/2015 2:20:47 AM : Outperform Start Price: $5.92 NASDAQ:ORMP Score: -89.16

Oramed , stock symbol (ORMP), is listed on the Nasdaq. It's home base is Jerusalem. They are developing pharmaceutical products. The most dramatic product they have is an insulin pill!!
Imagine being able to take an insulin capsule orally instead of taking an insulin shot! Millions
of diabetics will ask their Doctor for an insulin pill
prescription. This could bring in Billions of Dollars to the Drug Company selling this pill. And the stock should be bringing lots of profits to the owners! ---At present the Oramed pill is being tested in the United States and seeking
approval by the FDA.--Other countries are giving
their approval. Russia has already granted their approval. So, who knows, Russia may get the insulin pill before the U.S.!! (I Hope Not!!)
Current price for ORMP is $5.81 on 6-25-15.
At this price we can "buy low, sell high".
For additional info. go to ORAMED.COM
I believe this stock is a winner!!

being able to administer insulin orally with a insulin capsule.

Leaderboard

Find the members with the highest scoring picks in ORMP.

Score Leader

kevrose31

kevrose31 (80.32) Score: +152.61

The Score Leader is the player with the highest score across all their picks in ORMP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kevrose31 80.32 1/10/2014 Underperform 1Y $24.39 -86.51% +66.10% +152.61 0 Comment
sln 73.20 2/4/2020 Outperform 5Y $5.04 -34.72% -7.34% -27.38 0 Comment
Eskilf 47.82 2/4/2020 Outperform 5Y $5.09 -35.36% -7.35% -28.01 0 Comment
slnoutperform < 20 2/4/2020 Outperform 5Y $5.09 -35.36% -7.35% -28.01 0 Comment
sublimeinvestor 31.59 12/4/2019 Outperform 5Y $5.40 -39.07% -0.90% -38.17 0 Comment
Plasmidologist 34.38 12/4/2019 Outperform 5Y $5.40 -39.07% -0.90% -38.17 0 Comment
bfitz3309 33.00 7/3/2018 Outperform 5Y $6.51 -49.46% +12.11% -61.57 1 Comment
Mangot1me 43.69 3/24/2015 Outperform 5Y $4.76 -30.88% +45.60% -76.48 0 Comment
jamz50patt < 20 6/25/2015 Outperform 3Y $5.92 -44.43% +44.74% -89.16 1 Comment
NHWeston102 78.01 8/16/2016 12/14/2019 Outperform 1Y $7.43 -55.72% +39.80% -95.52 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ORMP.